|
KPTI Karyopharm Therapeutics Inc 1503802 |
| Balance Sheet |
|
Current Assets
|
$106,378,000.00 |
|
Assets
|
$111,317,000.00 |
|
Current Liabilities
|
$134,233,000.00 |
|
Liabilities
|
$441,485,000.00 |
|
Equity
|
$-330,168,000.00 |
|
Shares Out
|
22680288.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-47,659,000.00 |
|
Investing Cash Flow
|
$-6,836,000.00 |
| Market Analysis |
Market Cap
|
$41,278,124.16 |
|
Price
|
$1.88 |
|
PB
|
2.00 |
|
EPS
|
-2.32 |
|
PS
|
0.31 |
|
FCF
|
$-47,659,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:46 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:37 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-12 |
-5.71 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-14 |
-1.24 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-4.32 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-3.82 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KPTI documents filed with the SEC.
KPTI Filings
Clear
